Ginkgo Bioworks
DNA
$0.93 (12.55%)
1D
1W
3M
1Y
5Y
ALL
Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 1 day ago • DNA
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in BiologyThe Motley Fool • 2 days ago • DNA
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher TodayPRNewsWire • 2 days ago • DNA
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud TechnologyThe Motley Fool • 14 days ago • DNA
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.